These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents. Levy Yurkovski I; Tadmor T Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234 [TBL] [Abstract][Full Text] [Related]
12. Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials. Sousa-Pimenta M; Martins Â; Mariz JM; Berraondo P Front Immunol; 2023; 14():1295293. PubMed ID: 38077330 [TBL] [Abstract][Full Text] [Related]
13. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome. Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702 [TBL] [Abstract][Full Text] [Related]
14. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax. Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791 [TBL] [Abstract][Full Text] [Related]
15. Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon. Pham N; Coombs CC; O'Brien S Expert Rev Hematol; 2024; 17(4-5):117-126. PubMed ID: 38693662 [TBL] [Abstract][Full Text] [Related]